Gujarat Themis Biosyn Ltd. (GUJTHEM)

Volume: 5,206Avg Vol 1W: 21,426Avg Vol 1M: 62,33052W Range:₹225.05₹479

NSE BSE www.gtbl.in

₹379.85▲ 0.33%

Key Ratios

Updated just now

Market Cap—

Current Price₹379.85

Previous Close₹378.6

High / Low (52w)₹479 / ₹225.05

Volume5,206

Avg Vol (1W)21,426

Avg Vol (1M)62,330

Stock P/E62.83

Book Value₹26.4

Dividend Yield—

ROE—

ROA—

Revenue (TTM)₹166 Cr

Revenue Growth—

Profit Margin—

Total Debt—

Shares Outstanding—

Face Value₹1

EPS (TTM)₹1

P/B14.6

Debt / Equity—

50 DMA₹385.29

200 DMA₹331.99

Day change+0.33%

Price Chart

₹379.85▼ 16.88% · 1Y

2025-10-21

2026-06-16

20-day avg volume: 60K shares

Cons

Revenue fell 12% YoY.
Stock trades at a high P/E of 63.

Quarterly Results

Metric	Mar 2026	Dec 2025	Sept 2025	Jun 2025	Mar 2025	Dec 2024	Sept 2024	Jun 2024	Mar 2024	Dec 2023	Sept 2023	Jun 2023	Mar 2023	Dec 2022	Sept 2022	Jun 2022	Mar 2022	Dec 2021	Sept 2021	Jun 2021	Mar 2021	Dec 2020	Sept 2020	Jun 2020	Mar 2020
Revenue	₹44 Cr	₹43 Cr	₹42 Cr	₹36 Cr	₹38 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr
EBITDA	₹15 Cr	₹17 Cr	₹18 Cr	₹12 Cr	₹15 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr
Net Profit	₹11 Cr	₹12 Cr	₹14 Cr	₹9 Cr	₹12 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr
EPS	1	1.14	1.31	0.83	1.1	1.19	0.97	1.82	2.19	1.79	8.63	12.2	8.05	6.75	12.87	12.23	6.74	4.9	9.49	8.89	3.99	5.14	7.81	3.84	7.54

Profit & Loss (Annual)

Metric	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2017	Mar 2015
Revenue	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹36 Cr	₹31 Cr
EBITDA	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr
Net Profit	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr
EPS	4.48	40.72	39.9	30.03	20.77	16.3	—	—

Balance Sheet

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Total Assets	₹503 Cr	₹301 Cr	₹221 Cr	₹166 Cr	₹0 Cr	₹0 Cr	₹0 Cr
Total Liabilities	₹216 Cr	₹53 Cr	₹20 Cr	₹17 Cr	₹0 Cr	₹0 Cr	₹0 Cr
Equity	₹288 Cr	₹248 Cr	₹201 Cr	₹149 Cr	₹0 Cr	₹0 Cr	₹0 Cr
Total Debt	₹162 Cr	₹30 Cr	₹3 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr

Cash Flow

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Operating	₹49 Cr	₹91 Cr	₹64 Cr	₹39 Cr	₹0 Cr	₹0 Cr	₹0 Cr
Investing	₹-172 Cr	₹-112 Cr	₹-55 Cr	₹-20 Cr	₹0 Cr	₹0 Cr	₹0 Cr
Financing	₹115 Cr	₹26 Cr	₹-9 Cr	₹-13 Cr	₹0 Cr	₹0 Cr	₹0 Cr
Free Cash Flow	₹-124 Cr	₹-25 Cr	₹-10 Cr	₹16 Cr	₹0 Cr	₹0 Cr	₹0 Cr

Shareholding

Promoter 70.86% Institutions 2.97% Public 26.16%

About Gujarat Themis Biosyn Ltd.

Pharmaceuticals · Pharmaceuticals - Indian - Bulk Drugs

Gujarat Themis Biosyn Limited engages in the manufacture of pharmaceuticals and medicinal chemicals in India. The company offers bulk drugs on job work basis in India. Its products include Rifamycin-S, an intermediate for the treatment of tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease; Rifamycin-O for the treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy; and Lovastatin. The company was incorporated in 1981 and is based in Mumbai, India.

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search